Survivin, a member of the inhibitor of apoptosis protein (IAP) family, is highly expressed in most cancers, including CRC, where it plays dual compounding pathogenic roles by promoting cell proliferation and inhibiting apoptosis [18]. This evidence concerns the gene BIRC5 and colorectal carcinoma.